CompletedPhase 3Phase 4ACTRN12607000475448

Does point of care troponin testing speed up care of cardiac patients in emergency?

A randomized controlled trial of point of care troponin estimation vs in-lab methods to reduce length of stay in Emergency Department cardiac patients.

Sponsor

Conrad Loten

Enrollment

300 participants

Start Date

Nov 5, 2007

Study Type

Interventional

Conditions

Possible Acute Coronary Syndrome in emergency patients

Summary

A randomized comparison of two types of troponin testing for ED patients.Currently ED patients with possible coronary syndromes wait significant times to be "cleared " or declared low enough risk for stress testing or discharge. One component of this wait is the time for troponin results to become available which may be reduced by using bedside or point of care(POC) tests.This could result in acute ED bed space being more efficiently utilized.Many other factors however may affect the speed of patient flow and a controlled trial will help to quantify this.

Eligibility

Sex: Both males and femalesMin Age: 25 Yearss

Plain Language Summary

Simplified for easier understanding

This study looks at does point of care troponin testing speed up care of cardiac patients in emergency?. It is open to both men and women aged 25 Years and older. Participants will be screened based on specific health criteria to see if they qualify. If you join, the research team will explain what is involved and monitor your health throughout the study.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Point of care troponin testing will be made available on some weeks.On other weeks the point of care troponin machine will be unavailable.The availability of the machine represents the intervention and the weeks that it is available will determined by computer generated randomization prior to the study and then concealed until the monday morning at the beginning of each week.At that time after opening that weeks allocation the machine will either be made available for use( which may save time for patients or not) or withdrawn for one week. If the machine is withdrawn for that week the clinical staff will be forced to use usual (laboratory bench-top methods) of testing troponin.The expected duration of the trial is 3 months assuming adequate numbers to power the study (150 in each arm)are recruited.

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12607000475448